“Exposure–Response Analysis Demonstrates Response to Tapinarof Is Driven by Local Effects at Sites of Application”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s50. https://doi.org/10.25251/skin.6.supp.50.